Stay updated on Nivolumab for High-Risk Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for High-Risk Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for High-Risk Prostate Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.1%
    Check dated 2024-09-04T03:40:33.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2.
    Difference
    0.1%
    Check dated 2024-08-13T22:24:57.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0 and now includes 5 locations, replacing the previous version v2.9.7.
    Difference
    0.4%
    Check dated 2024-07-23T14:11:12.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7, replacing the previous version v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T07:39:38.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T12:34:02.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-27T09:23:23.000Z thumbnail image

Stay in the know with updates to Nivolumab for High-Risk Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for High-Risk Prostate Cancer Clinical Trial page.